Search Results 851-860 of 20856 for medication and sexual functioning

1. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   The reliability of sexual abstinence should be ... Angina pectoris requiring anti-angina medication; ... Renal function with creatinine clearance < 50 mL ...

2. Publications - Ekta Kapoor, M.B.B.S. - Mayo Clinic

   The Relationship Between Sleep and Sexual Function in Women Current Sexual Health Reports. 2022. Kapoor E, Faubion SS, Gazzuola Rocca L, Mielke MM, Smith CY ...

3. Medical Research & Education - Mayo Clinic News Network

   Study explores impact of childhood trauma on sexual function in midlife women featured image ... August 2, 2023. 2023 Gerstner Awardee's 'evolutionary therapy' ...

4. Collagenase clostridium histolyticum (injection route) - Side effects & uses - Mayo Clinic

   This medicine should come with a Medication Guide. ... Do not have sexual intercourse or have any sexual ... loss in sexual ability, desire, drive, or performance ...

5. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

   Glutamate is a chemical messenger that is important for many brain functions, including learning and memory. In Alzheimer's, certain disease processes cause too ...

6. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

   ... treatment. Male participants, if not surgically sterilized, and if engaging in sexual intercourse with a female partner of childbearing potential, must be ...

7. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily by ...

8. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   ... drug (for male patients who are sexually active with WOCBP). ... Patients must have FEV1/FVC > 60% by pulmonary function test (PFT), unless due to large ...

9. Venetoclax And Vincristine Liposomal In Treating Patients With Relapsed Or Refractory T-cell Or B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

   By condition, treatment or drug name. Search tips ... sexual orientation or whether they have undergone ... ECOG performance status 0-2. ELIGIBILITY ...

10. Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Mayo Clinic

    * Eastern Cooperative Oncology Group Performance Status (PS) 0, 1, or 2 * ... sexual intercourse or to use two methods of ... * Any of the following medication ...